Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Josuel Ora, Angelo Coppola, Mario Cazzola, Luigino Calzetta & Paola Rogliani. (2020) Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 559-574.
Read now
Read now
Erminia Ridolo, Irene Pellicelli, Bruna Gritti & Cristoforo Incorvaia. (2019) Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide. Patient Preference and Adherence 13, pages 145-150.
Read now
Read now
Kentaro Machida, Tomotaka Kawayama, Masaharu Kinoshita, Masakazu Ichinose, Tohru Tsuda, Shohei Takata, Hiroshi Koto, Makoto Yoshida, Yoshinori Ashihara, Masaru Kawashima, Hideaki Suna & Hiromasa Inoue. (2019) Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2175-2184.
Read now
Read now
Mohamed Ismail Abdul Aziz, Ling Eng Tan, David Bin-Chia Wu, Fiona Pearce, Gerald Seng Wee Chua, Liang Lin, Ping-Tee Tan & Kwong Ng. (2018) Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3203-3231.
Read now
Read now
Donald P Tashkin & Nicholas J Gross. (2018) Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1873-1888.
Read now
Read now
Anthony D D’Urzo, Peter Kardos & Russell Wiseman. (2018) Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1089-1104.
Read now
Read now
Anthony D D’Urzo, Mario Cazzola, Nicola A Hanania, Roland Buhl & M Reza Maleki-Yazdi. (2018) New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2805-2819.
Read now
Read now
Peter M. A. Calverley, Helgo Magnussen, Marc Miravitlles & Jadwiga A. Wedzicha. (2017) Triple Therapy in COPD: What We Know and What We Don't. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:6, pages 648-662.
Read now
Read now
Mark A. Mastrodicasa, Christopher A. Droege, Aaron M. Mulhall, Neil E. Ernst, Ralph J. Panos & Muhammad A. Zafar. (2017) Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs. Expert Opinion on Investigational Drugs 26:2, pages 161-174.
Read now
Read now
Marco Contoli, Paolo Solidoro, Fabiano Di Marco, Nicola Scichilone, Angelo Corsico, Fulvio Braido & Pierachille Santus. (2016) Effects of aclidinium on determinants of COPD severity: symptoms and quality of life. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3043-3050.
Read now
Read now
Thomas M Siler, Alison C Donald, Dianne O’Dell, Alison Church & William A Fahy. (2016) A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 971-979.
Read now
Read now
Articles from other publishers (17)
Pauline Henrot, Edmée Eyraud, Elise Maurat, Sophie Point, Guillaume Cardouat, Jean-François Quignard, Pauline Esteves, Thomas Trian, Pierre-Olivier Girodet, Roger Marthan, Maéva Zysman, Patrick Berger & Isabelle Dupin. (2022) Muscarinic receptor M3 activation promotes fibrocytes contraction. Frontiers in Pharmacology 13.
Crossref
Crossref
Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson & Jeffry Weers. (2022) Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews 74:1, pages 48-118.
Crossref
Crossref
Chuchu Zhang, Meng Zhang, Yalei Wang, Huaiyu Xiong, Qiangru Huang, Tiankui Shuai & Jian Liu. (2023) Efficacy and Cardiovascular Safety of LAMA in Patients with COPD: A Systematic Review and Meta-Analysis. Journal of Investigative Medicine 69:8, pages 1391-1398.
Crossref
Crossref
Harm Maarsingh, Anouk Oldenburger, Bing Han, Annet B. Zuidhof, Carolina R. S. Elzinga, Wim Timens, Herman Meurs, Ramadan B. Sopi & Martina Schmidt. (2021) Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction. Cells 10:5, pages 1237.
Crossref
Crossref
Hiroaki Kume. 2021. Lung Inflammation in Health and Disease, Volume I. Lung Inflammation in Health and Disease, Volume I
139
172
.
María Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporando nuevas evidencias sobre medicamentos inhalados en la EPOC. Asociación Latinoamericana de Tórax (ALAT) 2019. Archivos de Bronconeumología 56:2, pages 106-113.
Crossref
Crossref
Maria Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporating new evidence on inhaled medications in COPD. The latin American chest association (ALAT) 2019. Archivos de Bronconeumología (English Edition) 56:2, pages 106-113.
Crossref
Crossref
Eric Derom, Guy G. Brusselle & Guy F. Joos. (2019) The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects. Therapeutic Advances in Respiratory Disease 13, pages 175346661984342.
Crossref
Crossref
Eneida M. Harrison & Victor Kim. (2019) Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease. Respiratory Medicine: X 1, pages 100009.
Crossref
Crossref
Agnieszka Sliwka, Milosz Jankowski, Iwona Gross-Sondej, Monika Storman, Roman Nowobilski & Malgorzata M Bala. (2018) Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2018:8.
Crossref
Crossref
Barbara J. Messinger-Rapport, Milta O. Little, John E. Morley & Julie K. Gammack. (2017) Clinical Update on Nursing Home Medicine: 2017. Journal of the American Medical Directors Association 18:11, pages 928-940.
Crossref
Crossref
David M. Halpin, Alan G. Kaplan & Richard K. Russell. (2017) Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Respiratory Medicine 128, pages 28-41.
Crossref
Crossref
Han Ni, Aung Htet & Soe Moe. (2017) Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2017:6.
Crossref
Crossref
Uwe Fricke, Lutz Hein & Ulrich Schwabe. 2017. Arzneiverordnungs-Report 2017. Arzneiverordnungs-Report 2017
55
135
.
Agnieszka Sliwka, Milosz Jankowski, Iwona Gross-Sondej, Roman Nowobilski & Malgorzata M Bala. (2016)
Once daily Long-acting beta
2
-agonists/Inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease
. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Donatella Mutolo, Elenia Cinelli, Ludovica Iovino, Tito Pantaleo & Fulvia Bongianni. (2016) Downregulation of the cough reflex by aclidinium and tiotropium in awake and anesthetized rabbits. Pulmonary Pharmacology & Therapeutics 38, pages 1-9.
Crossref
Crossref
Tara Rheault, Sanjeev Khindri, Mitra Vahdati-Bolouri, Alison Church & William A. Fahy. (2016)
A randomised, open-label study of umeclidinium
versus
glycopyrronium in patients with COPD
. ERJ Open Research 2:2, pages 00101-2015.
Crossref
Crossref